Mon, Jul 28, 2014, 12:29 PM EDT - U.S. Markets close in 3 hrs 31 mins

Recent

% | $
Click the to save as a favorite.

Trius Therapeutics, Inc. (TSRX) Message Board

  • beavertail_splash beavertail_splash Mar 25, 2013 8:46 AM Flag

    Ted is proved better than LIN on tolerance

    "As in the ESTABLISH 1 study, both tedizolid and linezolid were generally well tolerated in ESTABLISH 2 with drug-related treatment emergent adverse events (TEAE) reported in 20.5% of tedizolid patients versus 24.8% of linezolid treated patients. Gastrointestinal adverse events were the most commonly reported of all TEAEs (16.0% in tedizolid vs. 20.5% in linezolid).

 
TSRX
13.63-0.05(-0.37%)Sep 11 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.